|
|
|
Insider
Information: |
Patel Sanj K |
Relationship: |
|
City: |
Lexington |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
63,012 |
|
Indirect Shares
|
109,795 |
|
|
Direct
Value |
$1,220,542 |
|
|
Indirect Value
|
$2,126,729 |
|
|
Total
Shares |
172,807 |
|
|
Total
Value |
$3,347,272 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Synageva BioPharma Corp |
GEVA |
President & CEO, Direc... |
2015-06-22 |
0 |
2015-06-22 |
0 |
Premium* |
|
Kiniksa Pharmaceuticals, Ltd. |
KNSA |
|
2024-04-08 |
63,012 |
2024-04-08 |
109,795 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
93 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
KNSA |
Kiniksa Pharmaceuticals, ... |
CHAIRMAN & CEO |
|
2023-03-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,002 |
39,038 |
0 |
- |
|
KNSA |
Kiniksa Pharmaceuticals, ... |
CHAIRMAN & CEO |
|
2023-03-20 |
4 |
D |
$11.12 |
$39,176 |
D/D |
(3,523) |
35,515 |
0 |
- |
|
KNSA |
Kiniksa Pharmaceuticals, ... |
CHAIRMAN & CEO |
|
2023-04-10 |
4 |
D |
$10.71 |
$31,412 |
D/D |
(2,933) |
42,574 |
0 |
- |
|
KNSA |
Kiniksa Pharmaceuticals, ... |
CHAIRMAN & CEO |
|
2023-04-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,992 |
45,507 |
0 |
- |
|
KNSA |
Kiniksa Pharmaceuticals, ... |
CHAIRMAN & CEO |
|
2023-09-01 |
4 |
D |
$17.76 |
$78,712 |
D/D |
(4,432) |
48,134 |
0 |
- |
|
KNSA |
Kiniksa Pharmaceuticals, ... |
CHAIRMAN & CEO |
|
2023-09-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,992 |
52,566 |
0 |
- |
|
KNSA |
Kiniksa Pharmaceuticals, ... |
CHAIRMAN & CEO |
|
2023-09-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,569 |
54,703 |
0 |
- |
|
KNSA |
Kiniksa Pharmaceuticals, ... |
CHAIRMAN & CEO |
|
2023-09-02 |
4 |
D |
$17.76 |
$38,841 |
D/D |
(2,187) |
52,516 |
0 |
- |
|
KNSA |
Kiniksa Pharmaceuticals, ... |
CHAIRMAN & CEO |
|
2024-03-04 |
4 |
AS |
$21.31 |
$273,834 |
I/I |
(12,742) |
70,594 |
0 |
% |
|
KNSA |
Kiniksa Pharmaceuticals, ... |
CHAIRMAN & CEO |
|
2024-03-06 |
4 |
AS |
$21.00 |
$117,222 |
I/I |
(5,582) |
65,012 |
0 |
% |
|
KNSA |
Kiniksa Pharmaceuticals, ... |
CHAIRMAN & CEO |
|
2024-03-07 |
4 |
AS |
$21.02 |
$1,366,552 |
I/I |
(65,012) |
0 |
0 |
% |
|
KNSA |
Kiniksa Pharmaceuticals, ... |
CHAIRMAN & CEO |
|
2024-04-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,482 |
58,998 |
0 |
- |
|
KNSA |
Kiniksa Pharmaceuticals, ... |
CHAIRMAN & CEO |
|
2024-04-01 |
4 |
D |
$19.70 |
$37,489 |
D/D |
(1,903) |
57,095 |
0 |
- |
|
KNSA |
Kiniksa Pharmaceuticals, ... |
CHAIRMAN & CEO |
|
2024-04-08 |
4 |
D |
$17.90 |
$72,943 |
D/D |
(4,075) |
63,012 |
0 |
- |
|
KNSA |
Kiniksa Pharmaceuticals, ... |
CHAIRMAN & CEO |
|
2024-04-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,992 |
67,087 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
Director and President/CEOOffi |
|
2011-11-02 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
286 |
|
- |
|
GEVA |
Synageva BioPharma Corp |
Director and President/CEOOffi |
|
2011-11-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,031 |
|
- |
|
GEVA |
Synageva BioPharma Corp |
President & CEO |
|
2012-03-23 |
4 |
AS |
$33.53 |
$1,676,410 |
D/D |
(50,000) |
1,031 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
President & CEO |
|
2012-03-23 |
4 |
OE |
$0.95 |
$47,500 |
D/D |
50,000 |
51,031 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
President & CEO |
|
2012-08-31 |
4 |
OE |
$0.95 |
$14,428 |
D/D |
15,187 |
16,218 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
President & CEO |
|
2012-08-31 |
4 |
AS |
$49.88 |
$757,518 |
D/D |
(15,187) |
1,031 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
President & CEO |
|
2012-09-04 |
4 |
AS |
$49.36 |
$2,705,372 |
D/D |
(54,813) |
1,031 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
President & CEO |
|
2012-09-04 |
4 |
OE |
$0.95 |
$52,072 |
D/D |
54,813 |
55,844 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
President & CEO |
|
2012-11-30 |
4 |
AS |
$48.87 |
$244,326 |
D/D |
(5,000) |
1,031 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
President & CEO |
|
2012-11-30 |
4 |
OE |
$0.95 |
$4,750 |
D/D |
5,000 |
6,031 |
0 |
- |
|
93 Records found
|
|
Page 2 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|